Galectin Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $36 | $0 |
Gross Profit | -2 | -10 | 18 | -9 |
EBITDA | -5,693 | -7,877 | -10,232 | -9,717 |
EBIT | -5,695 | -7,887 | -10,242 | -9,726 |
Net Income | -7,521 | -9,631 | -11,967 | -11,220 |
Net Change In Cash | 0 | 0 | 36 | 0 |
Free Cash Flow | -6,602 | -7,689 | -12,791 | -8,538 |
Cash | 13,771 | 7,431 | 15,120 | 27,060 |
Basic Shares | 63,447 | 63,204 | 62,739 | 62,278 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -37 | -33 | -32 | -41 |
EBITDA | -41,470 | -38,241 | -38,268 | -29,997 |
EBIT | -41,507 | -38,274 | -38,300 | -30,038 |
Net Income | -47,047 | -41,066 | -38,776 | -30,527 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -41,767 | -32,965 | -31,056 | -24,308 |
Cash | 15,120 | 25,660 | 18,592 | 39,648 |
Basic Shares | 62,309 | 60,159 | 59,391 | 58,527 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.12 |
2025-03-31 | -$0.19 |
2024-12-31 | -$0.19 |
